Salesforce Ventures participated in a $15m round for workplace collaboration tool developer Qatalog.

Intel Capital led the cybersecurity software developer's series A round, which boosted its overall funding to $20m.

Corvus spinoff Angel has secured series A funding from investors including Tigermed, Betta Pharmaceuticals and Hisun Pharmaceuticals.

Cambrian Biopharma co-led a $28.5m round for cancer immunotherapy developer Sensei Biotherapeutics with venture capital firm H&S Ventures.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Medical transcription technology provider Abridge has emerged from stealth with seed and series A funding.

Kidney disease-focused drug developer Walden was co-founded by faculty members of Rush University and Harvard University earlier this year.

UCB Pharma co-led a series A round for the kidney disease-focused drug developer through its UCB Ventures vehicle.

Medical transcription technology provider Abridge has emerged from stealth with seed and series A funding.

The health management app developer has completed a series A round led by Reckitt Benckiser, which had previously invested last year.